Tellimer

US : Tarsus Pharmaceuticals, Inc. - TARS | 1Q21 Financial Results and Lyme Disease Update


Most Viewed See latest
Disclosures

This publication is being distributed by Tellimer solely for information purposes irrespective of a particular user's means, financial situation or investment objectives. The information does not con...

Full Tellimer disclaimers